<PAGE> 1
--------------------------
OMB APPROVAL
--------------------------
OMB Number: 3235-0145
Expires: 31-Aug-99
Estimated Average burden
hours per reponse
--------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. _________)*
MONARCH DENTAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, par value $.01
- --------------------------------------------------------------------------------
(Title of Class of Securities)
609044 10 2
- --------------------------------------------------------------------------------
(CUSIP Number)
(Continued on the following pages)
(Page 1 of 4 Pages)
- ------------------------
Check the following box [ ] if a fee is being paid with this statement. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
- --------------------- -----------------
CUSIP No. 699044 10 2 SCHEDULE 13G Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Advent VII L.P. 04-3181563
Advent New York L.P. 04-3095408
Advent Atlantic and Pacific II L.P. 04-3123521
TA Venture Investors L.P. 04-3068354
TA Associates VII L.P. 04-3081388
TA Associates, Inc. 04-3205751
TA Associates Service Corporation 04-3214469
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Advent VII L.P. Delaware
Advent New York L.P. Delaware
Advent Atlantic and Pacific II L.P. Delaware
TA Venture Investors L.P. Massachusetts
TA Associates VII L.P. Delaware
TA Associates, Inc. Delaware
TA Associates Service Corporation Massachusetts
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
NUMBER OF -------------------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY N/A
EACH -------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH: Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
N/A
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
Advent VII L.P. 6.95%
Advent New York L.P. 1.53%
Advent Atlantic and Pacific II L.P. 5.29%
TA Venture Investors L.P. 0.25%
TA Associates VII L.P. 0.16%
TA Associates, Inc. 0.02%
TA Associates Service Corporation 0.02%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
Each entity is a Limited Partnership
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
ATTACHMENT TO FORM 13G Page 3
ITEM 1(a) NAME OF ISSUER: Monarch Dental Corporation
ITEM 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
6787 Arapaho Road
Suite 779
Dallas, TX 75248
ITEM 2(a) NAME OF PERSON FILING:
Advent VII L.P.
Advent New York L.P.
Advent Atlantic and Pacific II L.P.
TA Venture Investors L.P.
TA Associates VII L.P
TA Associates, Inc.
TA Associates Service Corporation
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE:
c/o TA Associates
125 High Street, Suite 2500
Boston, MA 02110
ITEM 2(c) CITIZENSHIP: Not Applicable
ITEM 2(d) TITLE AND CLASS OF SECURITIES: Common
ITEM 2(e) CUSIP NUMBER: 609044 10 4
ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A:
Not Applicable
ITEM 4 OWNERSHIP
ITEM 4(a) AMOUNT BENEFICIALLY OWNED: COMMON STOCK
------------
Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
ITEM 4(b) PERCENT OF CLASS PERCENTAGE
----------
Advent VII L.P. 6.95%
Advent New York L.P. 1.53%
Advent Atlantic and Pacific II L.P. 5.29%
TA Venture Investors L.P. 0.25%
TA Associates VII L.P. 0.16%
TA Associates, Inc. 0.02%
TA Associates Service Corporation 0.02%
ITEM 4(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR DIRECT THE VOTE: COMMON STOCK
------------
Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE: N/A
(iii) SOLE POWER TO DISPOSE OR DIRECT THE
DISPOSITION: COMMON STOCK
------------
Advent VII L.P. 829,029
Advent New York L.P. 182,885
Advent Atlantic and Pacific II L.P. 631,433
TA Venture Investors L.P. 29,853
TA Associates VII L.P. 18,504
TA Associates, Inc. 1,989
TA Associates Service Corporation 1,989
(iv) SHARED POWER TO DISPOSE OR DIRECT THE DISPOSITION N/A
<PAGE> 4
Page 4
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not Applicable
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
Not Applicable
ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY THAT ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
Not Applicable
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
This schedule 13G is filed pursuant to Rule 13d-1 (c). For the
agreement of group members to a joint filing, see below.
ITEM 9 NOTICE OF DISSOLUTION OF GROUP: Not Applicable
ITEM 10 CERTIFICATION: Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
AGREEMENT FOR JOINT FILING
Advent VII L.P., Advent New York L.P., Advent Atlantic and Pacific II L.P., TA
Venture Investors Limited Partnership, TA Associates VII L.P., TA Associates,
Inc. and TA Associates Service Corporation hereby agree that TA Associates shall
file with the Securities and Exchange Commission a joint schedule 13G on behalf
of the above-named parties concerning their beneficial ownership of Monarch
Dental Corporation.
Dated:
ADVENT VII L.P.
By: TA Associates VII L.P., its General Partner
By: TA Associates, Inc. its General Partner
By: _________________________________________________________
Katherine S. Cromwell, Managing Director
ADVENT ATLANTIC AND PACIFIC II L.P.
By: TA Associates AAP II Partners L.P., its General Partner
By: TA Associates, Inc. its General Partner
By: _________________________________________________________
Katherine S. Cromwell, Managing Director
ADVENT NEW YORK L.P.
By: TA Associates VI L.P., its General Partner
By: TA Associates, Inc. its General Partner
By: _________________________________________________________
Katherine S. Cromwell, Managing Director
TA VENTURE INVESTORS L.P.
By: _________________________________________________________
Katherine S. Cromwell, General Partner
TA ASSOCIATES VII L.P.
By: TA Associates, Inc.
By: _________________________________________________________
Katherine S. Cromwell, Managing Director
TA ASSOCIATES, INC.
By: _________________________________________________________
Katherine S. Cromwell, Managing Director
TA ASSOCIATES SERVICE CORPORATION
By: _________________________________________________________
Katherine S. Cromwell, Clerk
